Cargando…
Dimethyl Fumarate Suppresses Demyelination and Axonal Loss through Reduction in Pro-Inflammatory Macrophage-Induced Reactive Astrocytes and Complement C3 Deposition
Dimethyl fumarate (DMF) is an oral agent for relapsing-remitting multiple sclerosis (RRMS). In this study, we investigated the therapeutic mechanism of DMF using experimental autoimmune encephalomyelitis (EAE). DMF treatment decreased the proliferation of T cells and the production of IL-17A and GM-...
Autores principales: | Yadav, Sudhir K., Ito, Naoko, Soin, Devika, Ito, Kouichi, Dhib-Jalbut, Suhayl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922578/ https://www.ncbi.nlm.nih.gov/pubmed/33669652 http://dx.doi.org/10.3390/jcm10040857 |
Ejemplares similares
-
Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy
por: Yadav, Sudhir Kumar, et al.
Publicado: (2023) -
Effect of switching glatiramer acetate formulation from 20 mg daily to 40 mg three times weekly on immune function in multiple sclerosis
por: Ito, Kouichi, et al.
Publicado: (2021) -
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b(+)CD4(+) T Cells in the CNS during Progressive EAE
por: Mindur, John E., et al.
Publicado: (2014) -
Surface Layer Protein A Expressed in Clostridioides difficile DJNS06-36 Possesses an Encephalitogenic Mimotope of Myelin Basic Protein
por: Mindur, John E., et al.
Publicado: (2020) -
Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
por: Yadav, Sudhir K., et al.
Publicado: (2022)